GURUFOCUS.COM » STOCK LIST » Healthcare » Healthcare Providers & Services » EvokAI Creative Labs Inc (OTCPK:OKAIF) » Definitions » Intrinsic Value: Projected FCF

OKAIF (EvokAI Creative Labs) Intrinsic Value: Projected FCF : $0.00 (As of Jun. 01, 2025)


View and export this data going back to 2022. Start your Free Trial

What is EvokAI Creative Labs Intrinsic Value: Projected FCF?

Since the intrinsic value calculations based on Discounted Cash Flow Intrinsic Value: DCF (FCF Based), or Discounted Earnings Intrinsic Value: DCF (Earnings Based) cannot be applied to companies without consistent revenue and earnings, GuruFocus developed a valuation model based on normalized Free Cash Flow and Book Value of the company. The details of how we calculate the intrinsic value of stocks are described in detail here.

As of today (2025-06-01), EvokAI Creative Labs's Intrinsic Value: Projected FCF is $0.00. The stock price of EvokAI Creative Labs is $0.11945. Therefore, EvokAI Creative Labs's Price-to-Intrinsic-Value-Projected-FCF of today is 0.0.

The historical rank and industry rank for EvokAI Creative Labs's Intrinsic Value: Projected FCF or its related term are showing as below:

OKAIF's Price-to-Projected-FCF is not ranked *
in the Healthcare Providers & Services industry.
Industry Median: 1.115
* Ranked among companies with meaningful Price-to-Projected-FCF only.

EvokAI Creative Labs Intrinsic Value: Projected FCF Historical Data

The historical data trend for EvokAI Creative Labs's Intrinsic Value: Projected FCF can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

EvokAI Creative Labs Intrinsic Value: Projected FCF Chart

EvokAI Creative Labs Annual Data
Trend Dec21 Dec22 Dec23
Intrinsic Value: Projected FCF
- - -

EvokAI Creative Labs Quarterly Data
Dec21 Mar22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24
Intrinsic Value: Projected FCF Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only - - - - -

Competitive Comparison of EvokAI Creative Labs's Intrinsic Value: Projected FCF

For the Health Information Services subindustry, EvokAI Creative Labs's Price-to-Projected-FCF, along with its competitors' market caps and Price-to-Projected-FCF data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


EvokAI Creative Labs's Price-to-Projected-FCF Distribution in the Healthcare Providers & Services Industry

For the Healthcare Providers & Services industry and Healthcare sector, EvokAI Creative Labs's Price-to-Projected-FCF distribution charts can be found below:

* The bar in red indicates where EvokAI Creative Labs's Price-to-Projected-FCF falls into.


;
;

EvokAI Creative Labs Intrinsic Value: Projected FCF Calculation

Since the intrinsic value calculations based on Discounted Cash Flow Intrinsic Value: DCF (FCF Based), or Discounted Earnings Intrinsic Value: DCF (Earnings Based) cannot be applied to companies without consistent revenue and earnings, GuruFocus developed a valuation model based on normalized Free Cash Flow and Book Value of the company.

The details of how we calculate the intrinsic value of stocks are described in detail here.

This method smooths out the free cash flow over the past 6-7 years, multiplies the results by a growth multiple, and adds a portion of Total Stockholders Equity.

Intrinsic Value: Projected FCF = ( Growth Multiple * Free Cash Flow (6 year avg) + 0.8 * Total Stockholders Equity (most recent) ) / Shares Outstanding (Diluted Average)

In the case of negative Total Stockholders Equity, the following formula is used (see Explanation section below for the reason):

Intrinsic Value: Projected FCF = ( Growth Multiple * Free Cash Flow (6 year avg) + Total Stockholders Equity (most recent) / 0.8 ) / Shares Outstanding (Diluted Average)



EvokAI Creative Labs  (OTCPK:OKAIF) Intrinsic Value: Projected FCF Explanation

The growth multiple is capped between 8.35 and 17.74.

Total Stockholders Equity weighting is more art than science and it should always be revisited in more detail when researching a company. Weightings from 0% to 100% to more than 100% are possible. 80% was chosen as a happy median after taking the above ideas into consideration.

EvokAI Creative Labs's Price-to-Intrinsic-Value-Projected-FCF for today is calculated as

Price-to-Intrinsic-Value-Projected-FCF=Share Price/Intrinsic Value: Projected FCF
=0.11945/
=

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


EvokAI Creative Labs Intrinsic Value: Projected FCF Related Terms

Thank you for viewing the detailed overview of EvokAI Creative Labs's Intrinsic Value: Projected FCF provided by GuruFocus.com. Please click on the following links to see related term pages.


EvokAI Creative Labs Business Description

Traded in Other Exchanges
N/A
Address
609 Granville Street, Suite 1600, PO Box 10068, Pacific Centre, Vancouver, BC, CAN, V7Y 1C3
EvokAI Creative Labs Inc is a medtech artificial-intelligence-powered company. It deploys machine learning models to search medical data and uncover insights to help improve health outcomes, patient experiences, drug development, preclinical and clinical decisions, and provide more accurate diagnoses. EvokAI tailors its AI algorithms across the whole healthcare system, from hospitals, private clinics, research institutions, pharmaceutical companies, and contract research organizations to medical professionals, patients, and healthy individuals aiming at preventing and early detecting any kind of disease and beyond, protecting the aging genome.